Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 6, 2025 • 8:31 PM ET

Date/Time Source News Release
08/02/2022 01:00 AM EDT PR Newswire NEXTSTELLIS® oral contraceptive has been nominated for the 2022 prix galien usa award for best pharmaceutical agent
07/29/2022 01:00 AM EDT PR Newswire MAYNE PHARMA AND GOODRX ANNOUNCE NEW INITIATIVE TO INCREASE AWARENESS OF NEXTSTELLIS® AND EXPAND ACCESS TO BIRTH CONTROL
09/21/2021 10:00 AM EDT PR Newswire FDA Approves LEXETTE (R) for Adolescent Plaque Psoriasis
03/04/2021 04:34 PM EST PR Newswire Mayne Pharma launches another generic oral contraceptive
10/26/2020 12:10 AM EDT PR Newswire New Data On Mayne Pharma's Tolsura® (SUBA®-itraconazole) Presented At IDWeek 2020
07/27/2020 10:00 AM EDT PR Newswire Mayne Pharma Launches Chlorzoxazone Tablet in the United States
06/24/2020 12:10 AM EDT PR Newswire Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP in the US
05/28/2020 05:23 AM EDT PR Newswire Mayne Pharma Executes 20 Year License and Supply Agreement for Novel Oral Contraceptive in Australia
05/22/2020 01:44 AM EDT PR Newswire Mayne Pharma launches BAC 300 capsules in the United States
04/16/2020 12:30 AM EDT PR Newswire Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA
Page
  • 1
  • 2

Additional News

As of June 6, 2025 • 8:31 PM ET

Date/Time Source News Release
08/24/2018 02:24 PM EDT SeekingAlpha Mayne Pharma Ltd. ADR 2018 Q4 - Results - Earnings Call Slides
02/23/2018 12:39 PM EST SeekingAlpha Mayne Pharma Ltd. ADR 2018 Q2 - Results - Earnings Call Slides
01/12/2018 11:52 AM EST SeekingAlpha HedgePath Pharmaceuticals: Some Primary Concerns Addressed And Mitigated Through Mayne Pharma Deal
Page
  • 1